These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 17933275

  • 1. [Cytotoxic examinations of various cyclodextrin derivatives on Caco-2 cells].
    Kiss T, Fenyvesi F, Kovácsné BI, Fehér P, Leposáné KR, Váradi J, Szente L, Fenyvesi E, Iványi R, Vecsernyés M.
    Acta Pharm Hung; 2007; 77(2):150-4. PubMed ID: 17933275
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the cytotoxicity of beta-cyclodextrin derivatives: evidence for the role of cholesterol extraction.
    Kiss T, Fenyvesi F, Bácskay I, Váradi J, Fenyvesi E, Iványi R, Szente L, Tósaki A, Vecsernyés M.
    Eur J Pharm Sci; 2010 Jul 11; 40(4):376-80. PubMed ID: 20434542
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxicity of different types of methylated beta-cyclodextrins and ionic derivatives.
    Kiss T, Fenyvesi F, Pasztor N, Feher P, Varadi J, Kocsan R, Szente L, Fenyvesi E, Szabo G, Vecsernyes M, Bacskay I.
    Pharmazie; 2007 Jul 11; 62(7):557-8. PubMed ID: 17718201
    [Abstract] [Full Text] [Related]

  • 4. Aggregation of cyclodextrins as an important factor to determine their complexation behavior.
    Bikádi Z, Kurdi R, Balogh S, Szemán J, Hazai E.
    Chem Biodivers; 2006 Nov 11; 3(11):1266-78. PubMed ID: 17193241
    [Abstract] [Full Text] [Related]

  • 5. Influence of cyclodextrins on the proliferation of HaCaT keratinocytes in vitro.
    Hipler UC, Schönfelder U, Hipler C, Elsner P.
    J Biomed Mater Res A; 2007 Oct 11; 83(1):70-9. PubMed ID: 17380497
    [Abstract] [Full Text] [Related]

  • 6. In vitro cytotoxicity of paclitaxel/beta-cyclodextrin complexes for HIPEC.
    Bouquet W, Boterberg T, Ceelen W, Pattyn P, Peeters M, Bracke M, Remon JP, Vervaet C.
    Int J Pharm; 2009 Feb 09; 367(1-2):148-54. PubMed ID: 18938234
    [Abstract] [Full Text] [Related]

  • 7. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov 09; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 8. Study of the relationship between lipid binding properties of cyclodextrins and their effect on the integrity of liposomes.
    Piel G, Piette M, Barillaro V, Castagne D, Evrard B, Delattre L.
    Int J Pharm; 2007 Jun 29; 338(1-2):35-42. PubMed ID: 17289314
    [Abstract] [Full Text] [Related]

  • 9. Improvement of antifungal activity of 10-undecyn-1-ol by inclusion complexation with cyclodextrin derivatives.
    Neoh TL, Tanimoto T, Ikefuji S, Yoshii H, Furuta T.
    J Agric Food Chem; 2008 May 28; 56(10):3699-705. PubMed ID: 18454543
    [Abstract] [Full Text] [Related]

  • 10. In vitro toxicity and permeation of cyclodextrins in Calu-3 cells.
    Matilainen L, Toropainen T, Vihola H, Hirvonen J, Järvinen T, Jarho P, Järvinen K.
    J Control Release; 2008 Feb 18; 126(1):10-6. PubMed ID: 18160169
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of cholesterol depletion as a marker of nephrotoxicity in vitro for novel β-cyclodextrin derivatives.
    Wang H, Xie X, Zhang F, Zhou Q, Tao Q, Zou Y, Chen C, Zhou C, Yu S.
    Food Chem Toxicol; 2011 Jun 18; 49(6):1387-93. PubMed ID: 21426923
    [Abstract] [Full Text] [Related]

  • 12. The effect of cyclodextrins on the aqueous solubility of a new MMP inhibitor: phase solubility, 1 H-NMR spectroscopy and molecular modeling studies, preparation and stability study of nebulizable solutions.
    Bertholet P, Gueders M, Dive G, Albert A, Barillaro V, Perly B, Cataldo D, Piel G, Delattre L, Evrard B.
    J Pharm Pharm Sci; 2005 Jul 14; 8(2):163-74. PubMed ID: 16124927
    [Abstract] [Full Text] [Related]

  • 13. Reactivity and antiproliferative activity of ferrocenyl-tamoxifen adducts with cyclodextrins against hormone-independent breast-cancer cell lines.
    Buriez O, Heldt JM, Labbé E, Vessières A, Jaouen G, Amatore C.
    Chemistry; 2008 Jul 14; 14(27):8195-203. PubMed ID: 18668496
    [Abstract] [Full Text] [Related]

  • 14. Randomly methylated β-cyclodextrin derivatives enhance taxol permeability through human intestinal epithelial Caco-2 cell monolayer.
    Fenyvesi F, Kiss T, Fenyvesi E, Szente L, Veszelka S, Deli MA, Váradi J, Fehér P, Ujhelyi Z, Tósaki A, Vecsernyés M, Bácskay I.
    J Pharm Sci; 2011 Nov 14; 100(11):4734-44. PubMed ID: 21660974
    [Abstract] [Full Text] [Related]

  • 15. Melarsoprol-cyclodextrins inclusion complexes.
    Gibaud S, Zirar SB, Mutzenhardt P, Fries I, Astier A.
    Int J Pharm; 2005 Dec 08; 306(1-2):107-21. PubMed ID: 16253447
    [Abstract] [Full Text] [Related]

  • 16. Investigation of transport of genistein, daidzein and their inclusion complexes prepared with different cyclodextrins on Caco-2 cell line.
    Daruházi AE, Kiss T, Vecsernyés M, Szente L, Szőke E, Lemberkovics E.
    J Pharm Biomed Anal; 2013 Oct 08; 84():112-6. PubMed ID: 23810850
    [Abstract] [Full Text] [Related]

  • 17. Cyclodextrins.
    Stella VJ, He Q.
    Toxicol Pathol; 2008 Jan 08; 36(1):30-42. PubMed ID: 18337219
    [Abstract] [Full Text] [Related]

  • 18. Formulation of rifampicin-cyclodextrin complexes for lung nebulization.
    Tewes F, Brillault J, Couet W, Olivier JC.
    J Control Release; 2008 Jul 14; 129(2):93-9. PubMed ID: 18514353
    [Abstract] [Full Text] [Related]

  • 19. [Colloid-physical characterization of supramolecular drug delivery systems].
    Süle A, Csempesz F.
    Acta Pharm Hung; 2008 Jul 14; 78(2):59-67. PubMed ID: 18807385
    [Abstract] [Full Text] [Related]

  • 20. Sparing methylation of beta-cyclodextrin mitigates cytotoxicity and permeability induction in respiratory epithelial cell layers in vitro.
    Salem LB, Bosquillon C, Dailey LA, Delattre L, Martin GP, Evrard B, Forbes B.
    J Control Release; 2009 Jun 05; 136(2):110-6. PubMed ID: 19331849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.